stock-detail (NLNK)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

4/24/2017 12:18 pm

4/24/2017 12:18 pm

4/24/2017 12:18 pm

4/24/2017 12:18 pm

4/24/2017 12:18 pm

4/21/2017 12:18 pm

4/21/2017 12:18 pm

4/21/2017 12:18 pm

4/21/2017 12:18 pm

4/21/2017 12:18 pm

4/21/2017 06:19 am

4/21/2017 06:19 am

4/21/2017 06:19 am

4/21/2017 06:19 am

4/21/2017 12:18 am

4/21/2017 12:18 am

4/21/2017 12:18 am

4/21/2017 12:18 am

4/20/2017 06:18 am

4/7/2017 06:17 am

TrovaGene and NewLink Genetics Find Investors Optimistic About Products

3/31/2017 01:03 pm

[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 31, 2017 / TrovaGene and NewLink Genetics stock rose in Thursday's trading session as both companies caught the attention of investors after optimism about their current ...

Blog Coverage PTC Therapeutics Acquires Rights for Duchenne Muscular Dystrophy Drug from Marathon for $140 Million Upfront

3/17/2017 12:01 pm

[Accesswire] - Upcoming AWS Coverage on NewLink Genetics Post-Earnings Results LONDON, UK / ACCESSWIRE / March 17, 2017 / Active Wall St. blog coverage looks at the headline from PTC Therapeutics, Inc. (NASDAQ: PTCT ...